Anvisa allows Ypê factory to resume production in Amparo

Anvisa authorized the resumption of activities at the Ypê factory in Amparo on Friday after an inspection confirmed corrections. Products from lot ending in 1 remain suspended.

The National Health Surveillance Agency authorized the immediate resumption of operations at Química Amparo, the manufacturer of Ypê products, at the factory located in Amparo, São Paulo. The decision followed a joint reinspection with state and municipal agencies that verified the adequacy of corrective actions implemented by the company.

Anvisa president Leandro Safatle stated that the factory meets conditions to operate safely. He visited the site on Friday, May 29, 2026, alongside director Daniel Meirelles.

Liquid products with lot numbers ending in 1, manufactured before April 1, 2026, remain banned due to contamination by Pseudomonas aeruginosa. The company must submit laboratory reports for possible future release.

The initial suspension occurred in early May after an inspection identified quality control failures at the unit.

Makala yanayohusiana

Anvisa officials reviewing Ypê detergent products for potential suspension, with concerned consumers nearby.
Picha iliyoundwa na AI

Anvisa to rule this Wednesday on Ypê product suspension

Imeripotiwa na AI Picha iliyoundwa na AI

Anvisa will rule this Wednesday (13) on a Ypê appeal that could reinstate the suspension of the brand's detergents, liquid laundry detergents and disinfectants. The measure affects lots ending in 1 made in Amparo (SP). Meanwhile, consumers seek guidance on refunds or exchanges.

Ypê filed an appeal against an Anvisa decision that suspended manufacturing and ordered the recall of products. The measure was automatically suspended until judgment by the agency's board.

Imeripotiwa na AI

Ypê has decided to continue offering exchanges or refunds to consumers who prefer to return products from the final batch 1, even after Anvisa ruled that the items do not need to be recalled immediately.

Fiocruz has completed the technology transfer for dolutegravir, the main antiretroviral used in HIV treatment by Brazil's SUS. Large-scale production now depends on ANVISA registration.

Imeripotiwa na AI

The Food and Drug Supervisory Agency has revoked distribution permits for 11 cosmetic products found to contain hazardous and prohibited substances following inspections in the first quarter of 2026.

Jumapili, 19. Mwezi wa saba 2026, 17:20:27

Gas leak in Manaus affects 414 people and triggers fines

Ijumaa, 19. Mwezi wa sita 2026, 12:26:18

Petrobras approves $1.2 billion investment in Cubatão

Alhamisi, 18. Mwezi wa sita 2026, 06:27:54

Anvisa orders recall of antibiotic batch with glass fragment

Jumatatu, 15. Mwezi wa sita 2026, 17:10:18

Rio Civil Police investigate clinic over injuries in 15 patients

Jumatatu, 15. Mwezi wa sita 2026, 05:53:53

Court overturns injunction as ANP starts hearing on abusive fuel prices

Ijumaa, 22. Mwezi wa tano 2026, 22:36:22

China suspends three Brazilian beef plants over banned residue

Alhamisi, 30. Mwezi wa nne 2026, 19:58:52

Anvisa bans manufacturing of Henlau Química cosmetics

Alhamisi, 30. Mwezi wa nne 2026, 08:07:20

Petrobras resumes urea production in Paraná after six years

Tovuti hii inatumia vidakuzi

Tunatumia vidakuzi kwa uchambuzi ili kuboresha tovuti yetu. Soma sera ya faragha yetu kwa maelezo zaidi.
Kataa